Effect of long-term octreotide and isosorbide dinitrate on haemodynamics in rats with portal vein stenosis

Clinical Science

Volumn 94, Issue 6, 1998, Pages 645-650

  Lin, Han Chieh ^a,b   Huang, Yi Tsau ^b   Cheng, Yuh Ren ^b   Hou, Ming Chih ^a,b   Lee, Fa Yauh ^a,b   Chang, Full Young ^a,b   Tsai, Yang Te ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Haemodynamics; Isosorbide dinitrate; Octreotide; Portal hypertension

Indexed keywords

ISOSORBIDE DINITRATE; OCTREOTIDE; RADIOACTIVE MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART INDEX; HEART RATE; INTRAGASTRIC DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASODILATATION;

EID: 0031809169     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940645     Document Type: Article

References (40)

1. Lebrec D. (1994) Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding. Pharmacol Ther 61: 65-107
2. Baur W, Briner U, Doepfner W, et al. (1982) SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31: 1133-40
3. Hwang SJ, Lin HC, Chang CF, et al. (1992) A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 16: 320-5.
4. Sung JJY, Chung SCS, Lai CW, et al. (1993) Octreotide infusion or emergency sclerotherapy for variceal hemorrhage. Lancet 342: 637-41.
5. Lin HC, Tsai YT, Lee FY, et al. (1992) Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 103: 229-34.
6. McCormick PA, Biagini MR, Dick R, et al. (1992) Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension. A double-blind, placebo-controlled study. Hepatology 16: 1180-6.
7. Cerini R, Lee SS, Hadengue A, Koshy A, Girod C, Lebrec D. (1988) Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension. Gastroenterology 94: 703-8.
8. + retention in portal hypertensive rats. Gastroenterology 104: 575-9.
9. Lin HC, Yang MCM, Hou MC, et al. (1996) Effects of long-term administration of octreotide in portal vein-stenosed rats. Hepatology 23: 537-43.
10. Sieber CC, Lee FY, Groszmann RJ. (1996) Long-term octreotide prevents vascular hyporeactivity in portal hypertensive rats. Hepatology 23: 1218-23.
11. Huang YT, Tsai JF, Liu TB, Hong CY, Yang MCM, Lin HC. (1996) Chronic administration of octreotide increases vascular responsiveness in rats with portal hypertension. Clin Sci 91: 601-6.
12. Sieber CC, Mosca PG, Groszmann RJ. (1992) Effects of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats. Am J Physiol 262: G274-7.
13. Waldman SA, Murad F. (1987) Cyclic GMP synthesis and function. Pharmacol Rev 39: 163-96.
14. Blei AT, Gottstein J. (1986) Isosorbide dinitrate in experimental portal hypertension: a study of factors that modulate the hemodynamic response. Hepatology 6: 107-11.
15. Bhathal PS, Grossmann HJ. (1985) Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1: 325-7.
16. Marteau P, Ballet F, Olivier C, et al. (1989) Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver. Hepatology 9: 820-3.
17. Kroeger RJ, Groszmann RJ. (1985) The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model. Hepatology 5: 425-30.
18. Garcia-Pagan JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodes J. (1990) Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 11: 230-8.
19. Groszmann RJ, Kravetz D, Bosch J, et al. (1982) Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology 2: 757-62.
20. Lin HC, Soubrane O, Lebrec D. (1991) Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats. Hepatology 14: 325-30.
21. Colombato LA, Sabba C, Polio L, Groszmann RJ. (1991) Influence of anesthesia, postanesthetic state, and restraint on superior mesenteric arterial flow in normal rats. Am J Physiol 240: G1-6.
22. Sikuler E, Buchs AE, Yaari A, Keynan A. (1991) Hemodynamic characterization of conscious and ketamine-anesthetized bile duct-ligated rats. Am J Physiol 260: G161-6.
23. Lin HC, Soubrane O, Cailmail S, Lebrec D. (1991) Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats. J Hepatol 13: 213-19.
24. Sarin K, Groszmann RJ, Mosca PG, et al. (1991) Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension. J Clin Invest 87: 1032-6.
25. Pizcueta MP, Garcia-Pagan JC, Fernandez M, Casamitjana R, Bosch J, Rodes J. (1991) Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation. Gastroenterology 101: 1710-15.
26. Tornebrandt K, Nobin A, Owman C. (1987) Contractile and dilatory action of neuropeptides on isolated human mesenteric blood vessels. Peptides 8: 251-6.
27. Kravetz D, Bosch J, Arderiu MT, et al. (1988) Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Am J Physiol 254: G322-8.
28. Lin HC, Tsai YT, Yang MCM, et al. (1996) Effect of octreotide on total effective vascular compliance in patients with posthepatic cirrhosis. J Hepatol 24: 81-7.
29. 2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 48: 875-84.
30. Flavahan NA, Rimele TJ, Cooke JP, Vanhoutte PM. (1984) Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J Pharmacol Exp Ther 230: 699-705.
31. Aboud RW, Connolly C, McCormick PA, Docherty JR. (1997) Vascular action of octreotide in the portal hypertensive rats. Br J Pharmacol 122: 698-702.
32. Lewis FW, Adair O, Rector WG. (1992) Arterial vasodilatation is not a cause of increased cardiac output in cirrhosis. Gastroenterology 102: 1024-9.
33. Abrams J. (1980) Nitroglycerin and long-acting nitrates. N Engl J Med 302: 1234-7.
34. Vatner SF, Pagani M, Rutherford JD, Millard RW, Manders WT. (1978) Effects of nitroglycerin on cardiac function and regional blood flow distribution in conscious dogs. Am J Physiol 234: H244-52.
35. Needleman P, Hohnson EM. (1960) Vasodilator and the treatment of angina. In: Gilman AG, Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. 6th edn. New York: Macmillan, pp. 819-33.
36. Guyton AC. (1991) Textbook of medical physiology. 8th edn. Philadelphia: W. B. Saunders, pp. 194-204.
37. Koshy A, Moreau R, Cerini R, et al. (1989) Effects of oxygen inhalation on tissue oxygenation in patients with cirrhosis. Evidence for an impaired arterial baroreflex control. J Hepatol 9: 240-5.
38. MacGilchrist AJ, Reid JL. (1990) Impairment of autonomic reflexes in cirrhosis. Am J Gastroenterol 85: 288-92.
39. Voigt MD, Trey G, Levitt NS, et al. (1997) Autonomic neuropathy in extra-hepatic portal vein thrombosis: evidence for impaired autonomic reflex arc. J Hepatol 26: 634-41.
40. Hori N, Okanoue T, Sawa Y, et al. (1994) Hemodynamic effects of a combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats. J Gastroenterol 29: 460-8.